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Introduction: Transplantation of endothelial progenitor cells (EPCs) restores endothelial function in patients
with endothelial dysfunction and initial denudation. The goal of the present study was to determine the effect
of cryopreserved human umbilical cord blood (UCB)-derived EPC infusion on the repair of carotid artery injury
in nude rats.
Methods: Mononuclear cells (MNCs) from human cryopreserved UCB and peripheral blood (PB) of patients with
cardiovascular diseases and healthy volunteers were cultured in a conditioned medium. The in vitro migration,
proliferation, adhesion, and survival capacities, as well as paracrine cytokine release of EPCs were investigated.
EPC homing, induced reendothelialization, and the effect on neointima formation were also assessed in vivo.
Results: Patient-derived PB EPCs (PPB-EPCs) displayed decreased migration, proliferation, adhesion, and survival
capabilities as compared to PB-EPCs from healthy volunteers (HPB-EPCs) and cryopreserved UCB-EPCs. However,
there was no difference in the release of vascular endothelial growth factor (VEGF) and stromal cell derived
factor 1 (SDF-1) between the three groups. Two weeks after transplantation, more labeled UCB-EPCs and
HPB-EPCs than PPB-EPCs were found by cell tracking in the injury zone. Administration of PPB-EPCs, HPB-EPCs,
and UCB-EPCs enhanced reendothelialization and inhibited neointima formation compared to the saline control.
However, UCB-EPC and HPB-EPC infusion showed a greater improvement than PPB-EPCs.
Conclusions: Cryopreserved UCB-MNCs derived EPCs and HPB-EPCs show better responses to cytokines and
vascular injury than PPB-EPCs. Thus, cryopreservation and delivery of cryopreserved autogenous UCB-EPCs or
HPB-EPCs may be a promising vasculoprotective approach for patients with multiple cardiovascular risk factors.Introduction
Endothelial dysfunction and initial denudation aremajor con-
tributing factors to vasoconstriction, neointima formation,
thrombosis, and atherosclerosis [1]. Previous experiments
have suggested that endothelial progenitor cells (EPCs)—der-
ived from hematopoietic stem cells (HSCs)—have the poten-
tial to incorporate into the site of vessel injury and
differentiate into endothelial cells, thereby contributing to the
improvement of endothelial function [2]. Transplantation of* Correspondence: zxhwn@tmmu.edu.cn
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© 2015 Yin et al.EPCs is currently under intensive investigation and has
proven to be a useful strategy in animalmodels and clinical re-
search [3]. However, growing evidence has shown that EPCs
from patients with cardiovascular risk factors, including
diabetes, hypertension, metabolic syndrome, smoking,
aging, and coronary artery disease, or other diseases,
such as emphysema, acute lung injury, liver fibrosis, and
systemic sclerosis, are associated with decreased number
and impaired function [4,5].
Umbilical cord blood (UCB) is a traditional source of
HSCs for the treatment of various diseases beyond
hematologic diseases such as Langerhans-cell histocytosis
and Bare-lymphocyte syndrome. UCB has been shown to
contain a large number of progenitors, and transplantation
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vessels by both directly differentiating into endothe-
lial cells and the release of paracrine factors [6]. In
contrast to adult EPCs, cord blood EPCs have a
higher proliferative capacity, rapid self-renewal, low
apoptosis, and express telomerase, a functional char-
acteristic of stem cells that is very low or absent in
other progenitor cell populations [7,8]. All of these
properties favor the exciting opportunity to obtain a
large quantity and high quality UCB-EPCs, compared
with peripheral blood (PB). Furthermore, UCB stem
cells can be extracted and cryopreserved, allowing
for future personal autotransplantation or matched-
patient use. Previous studies have shown that cryo-
preserved UCB-mononuclear cells (MNCs) can differen-
tiate into EPCs in conditioned medium, and exhibit
similar properties to those of fresh UCB in vitro and
in vivo [9-11].
In this study, we compared the effect of cryopreserved
human UCB-derived EPCs, PB-derived EPCs from patients
with cardiovascular risk factors (PPB-EPCs), and PB derived
EPCs of healthy volunteers (HPB-EPCs) on the repair
of carotid artery injury in nude rats.
Methods
Human peripheral blood-mononuclear cells
All experiments in this study were conducted in accordance
with the Position of the American Heart Association on
Research and Animal Use adopted by the American
Heart Association and the guidelines of the Institutional
Animal Care and Use Committee of Third Military
Medical University. Written informed consent was obtained
from all patients and normal subjects before enrollment in
the study. All aspects that involved human or human tissue
in our study were approved by Committees of Ethics
at Third Military Medical University. Patients with
cardiovascular diseases (n = 25, Table 1) and healthy
volunteers (n = 25, Table 1) were included in the study.
MNCs were isolated by density gradient centrifugation
using a Histopaque density centrifugation method (Sigma,





Age (years) 64.04 ± 11.13 62.87 ± 9.75
Sex (men) 18 15
Smokers 13 0
LDL >130 mg/dL 7 0
Coronary artery disease 18 0
Diabetes 4 0
Hypertension 14 0UCB-MNC freezing and thawing
UCB was collected from umbilical veins after neonatal
delivery by a cord blood bank (Sichuan province, China)
with informed consent from pregnant mothers. Freezing
and thawing of UCB-MNCs was performed according to
previously described methods [9,10]. Briefly, human UCB
samples (40 to 90 mL) from female full-term newborns
were collected from a fresh umbilical cord attached to the
placenta and MNCs were isolated from the collected
blood using the Histopaque density centrifugation
method. The collected MNC layers from UCB were
washed three times with phosphate-buffered saline
(PBS, Sigma) and suspended at 5 × 107 cells/mL with
a final concentration of 10% dimethyl sulfoxide (DMSO)
(Sigma) and 20% fetal bovine serum (FBS) (Sigma).
Then the cryotubes were transferred to a programmed
cryopreservation box and stored in liquid nitrogen
(−196°C). UCB samples that had been in cryostorage
for two to five years were used for this study.
The cryotubes were thawed very rapidly in a 37°C
water bath and the MNCs were immediately transferred
to 50 mL thawing medium containing 5% FBS + DNase I
(20 U/mL, Roche, Shanghai, China). Then, the MNCs were
centrifuged at 300 × g for 15 minutes at room temperature.
The supernatant was removed and then MNCs were resus-
pended and plated on fibronectin-coated 24-well plates
(1 × 106/cm2, Sigma) in 0.5 mL Dulbecco’s modified
Eagle’s medium (DMEM, Gibco, Carlsbad, CA, USA)
supplemented with 20% FBS.
EPC culture
EPCs were cultured according to previously described
techniques [12]. Briefly, MNCs were plated on fibronectin-
coated 24-well plates (1 × 106/cm2) in 0.5 mL DMEM
supplemented with 20% FBS, vascular endothelial growth
factor (VEGF, 50 ng/mL), basic fibroblast growth factor
(bFGF, 5 ng/mL), epidermal growth factor (EGF, 10 ng/mL),
penicillin (100 U/mL), and streptomycin (100 μg/mL). Four
days after culturing, nonadherent cells were removed by
thorough washing with PBS. The medium was changed
every three days.
EPC characterization
EPCs were characterized according to previously described
techniques [13]. After seven days, cells were incubated with
2.4 ng/mL DiI-labeled acetylated low-density lipoprotein
(DiI-LDL, Molecular Probes, Waltham, MA, USA) at 37°C
for one hour. Then the cells were washed with PBS three
times and fixed with 2% paraformaldehyde (PFA, Beijing
CellChip Biotechnology, Beijing, China) for 10 minutes.
After washing with PBS, the cells were stained with a
fluorescein isothiocyanate (FITC)-labeled lectin from ulex
europaeus agglutinin (UEA, Vector Labs, Burlingame,
CA, USA) for one hour. Samples were washed with
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(Olympus, Tokyo, Japan). Double-labeled fluorescence
cells were identified as differentiating EPCs. The negative
control was incubated with PBS instead of DiI-LDL
and UEA.
The cells were labeled with 1 mg/L FITC or phyco-
erythrin (PE)-conjugated mouse antihuman CD31-PE
(Beckman Coulter, Paris, France), CD45-FITC, CD34-
FITC, and VEGFR2-PE (BD Biosciences, Franklin Lakes,
NJ, USA) monoclonal antibodies for 30 minutes at 4°C
in PBS. FITC- or PE-conjugated mouse immunoglobulin
G (IgG) was used as an isotype control at the same
concentration. The fluorescence intensity of the cells was
evaluated by flow cytometry using a flow cytometer (BD
Biosciences), and the data were analyzed with CellQuest
software (BD Biosciences).
Human umbilical venous endothelial cells (HUVECs)
isolated and pooled from umbilical cords obtained from
normal vaginal deliveries (Cell Applications, San Diego,
CA, USA) were passaged three times and used as the
positive control.EPC migration assay
EPC migration was evaluated using a modified Boyden
chamber (Chemicon, Temecula, CA, USA) as previously
described [14]. Stromal cell derived factor-1 (SDF-1,
Sigma) was diluted to 100 ng/mL in DMEM and 25 μL
of the final dilution was placed in the lower chamber.
EPCs (2.5 × 105) suspended in 50 μL DMEM were seeded
in the upper compartment. After six hours incubation at
37°C, the lower side of the filter was washed with
PBS and fixed with 2% PFA. For quantification, cells
were stained with Giemsa solution (Sagene, Guangzhou,
China). Cells that had migrated into the lower chamber
were counted manually in five random high-power
fields (n = 9). Control experiments were performed by
stimulation with PBS. The experiments were repeated
three times.EPC proliferation assay
The proliferation assay was performed as previously
described [12]. Briefly, EPCs were digested with 0.25%
trypsin (Sagene) and then seeded in 96-well culture
plates (Sigma). After overnight culture in phenol red-free
DMEM, cells were incubated with 100 ng/mL rhVEGF
(ProSpec, East Brunswick, NJ, USA) for 24 hours. Before
the optical density measurement (562 nm, Tecan, Zurich,
Switzerland) was performed, EPCs were supplemented
with 10 μL MTT (5 g/L, Gibco) for another six hours and
200 μL DMSO for 10 minutes.
Mitogenic activity was further evaluated by cell counting.
EPCs were seeded in six-well plates (Sigma) at a density of
5 × 105 cells per well in phenol red-free DMEM overnight,and then exposed to 100 ng/mL rhVEGF for another
24 hours.
Cell adhesion assay
The cell adhesion assay was performed as previously
described [14]. Briefly, EPCs were incubated with SDF-1α
(100 ng/mL) for 12 hours and detached as described
above. After centrifugation and resuspension in EBM
(endothelial basal medium) (Cell Systems, Kirkland,
WA, USA) with 5% (v/v) FBS, identical cells were plated
onto fibronectin-coated culture dishes and incubated for
30 minutes at 37°C. Adherent cells were counted in three
random microscopic fields (×400).
Apoptosis assay
Apoptosis assays were carried out using an annexin V
apoptosis detection kit (Alexis Biochemicals, Farmingdale,
NY, USA), according to the manufacturer’s instructions
[15]. EPCs were incubated with 50 mg/L TNF-α
(Sigma) for four days and then stained with annexin V
FITC and propidium iodide (PI). To exclude necrotic
cells, only annexin-positive cells were subjected to
flow cytometric analysis. Data are provided as the
mean (SEM) of the percentage of annexin V+/PI− cells
(apoptotic cells).
Western blot analysis
Cells were incubated with lysis buffer (Sagene) for
20 minutes at 4°C. After centrifugation for 15 minutes at
20,000 × g (4°C), the protein concentration was quanti-
fied for each sample and 50 μg per lane was loaded
onto SDS-polyacrylamide gels (Pharmacia Biotech,
Buckinghamshire, UK). The separated proteins were elec-
trotransferred to nitrocellulose membranes (Pharmacia
Biotech) and probed with antibodies against VEGF and
SDF-1 (1:1000 dilution, R&D Systems, Minneapolis,
MN, USA). The membranes were then incubated with
a horseradish peroxidase (HRP)-conjugated secondary
antibody (R&D Systems, 1:2000) for two hours, and reacted
with the chromogenic substrate 3,3’-diaminobenzidine
(DAB, Sigma). Blots were reprobed with GAPDH (1:2000,
Sigma). The autoradiographs were scanned and analyzed
semi-quantitatively.
Enzyme-linked immunosorbent assay
ELISAs were performed according to the manufacturer’s
instructions (R&D Systems). Briefly, 1 × 106 cells were
incubated with 1 mL DMEM without supplements for
24 hours. The medium was collected and 20× concentrated
by centrifugation at 4°C (5000 × g for 20 minutes) using
Ultrafree-4 centrifugal filter tubes with Biomax-5
membranes (Millipore, Billerica, MA, USA). VEGF and
SDF-1 were then measured in concentrated culture
supernatants by ELISA.
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Carotid artery injury and EPC transplantation was
performed using previously described methods [16].
Heparin (Wanbang, Shanghai, China) was intraperitoneally
administered at a dosage of 300 U/kg. After 30 minutes,
six-week-old female nude rats (Laboratory Animal
Department of Shanghai Public Health Clinical Center)
were anesthetized with 50 mg/kg sodium pentobarbital
(Xinhua, China) injected intraperitoneally. Left carotid
arteries were exposed through a midline incision in the
neck. Silk sutures (6–0, Suzhou Medical Appliance
Factory, Suzhou, China) were placed around the common,
internal, and external carotid arteries to temporarily
restrict blood flow to the area of surgical manipulation. A
1.5 F Fogarty arterial embolectomy catheter (Baxter,
Deerfield, IL, USA) was inserted through the external
carotid artery, inflated with 150 μL of air, and passed
three times along the length of the segment. The total
length of denuded common carotid artery was 10 mm
from the bifurcation of carotid arteries in all animals.
Then the external carotid artery was permanently ligated.
The temporary ligatures were released to allow blood
flow to be restored through the internal carotid artery.
The skin was closed with single sutures using 6–0 silk.
Animals were euthanized and carotid arteries were
harvested at indicated time points after induction of
carotid artery injury.
Labeled EPCs (1 × 106) were incubated with 2.4 μg/mL
DiI-LDL (Molecular Probes) for one hour. Then the
cells were washed with PBS three times and injected
into the rats’ tail vein in 200 μL saline after induction
of arterial injury.
Assessment of reendothelialization
Assessment of reendothelialization was performed
according to previously described methods [13]. One
week after carotid artery injury and labeled EPC
transplantation, 200 μL of 5% Evans blue (Sigma) was
injected into the heart with a 27-gauge needle (Suzhou
Medical Appliance Factory). Then 4% PFA (Sigma) was
administered for perfusion fixation. The remaining
endothelium-denuded site(s) within the harvested arterial
segment was measured using Image-Pro Plus 5.1 (Media
Cybernetics Inc., Bethesda, MD, USA) by one analyst,
who was blinded to the treatment regimen. The ini-
tially denuded area was defined as the total surface
area of the harvested arterial segment. The length of
the harvested segment corresponded to the total
length of the injured segment; in each case, this
length was similarly defined proximally by the carotid
bifurcation and distally by the edge of the omohyoid
muscle. The reendothelialized area was defined macro-
scopically as the area that was not stained with Evans
blue dye. In addition to Evans blue staining, scanningelectron microscopy was performed to evaluate endo-
thelial recovery and morphology. Samples for electron
microscopy were fixed and processed using a standard
technique.
Measurement of medial and neointimal area
Measurement of the medial and neointimal areas was
performed according to previously described methods
[13]. Three weeks after carotid artery injury, the left
common carotid artery was harvested 10 mm from the
carotid bifurcation. After perfusion fixation with 2% PFA
and paraffin-embedding, carotid cross-sections (5 μm)
were stained with hematoxylin and eosin (Boyao Bio,
Shanghai, China) and Verhoeff van Geison (GenMed,
Shanghai, China) according to standard protocols. All
sections were examined under an inverted microscope
(Leica, Wetzlar, Germany). Morphometric analysis of
the medial and neointimal area was performed with
Image-Pro Plus 5.1 (Media Cybernetics Inc., Bethesda,
MD, USA). Endoluminal, internal elastic laminar, and
external elastic laminar borders were manually traced with
the software (Image ProPlus) to calculate the intimal and
medial areas of 15 sections per animal.
Statistical analysis
All values were expressed as the mean ± standard devi-
ation (SD). Differences between data were analyzed with
analysis of variance (ANOVA) followed by Fisher’s Least
Significant Difference (LSD) using SPSS19.0. P <0.05
was considered to be statistically significant.
Results
Characterization of cultured EPCs
Cryopreserved UCB-MNCs cultured under endothelial-
specific conditions developed into normal cell colonies
by day 7 after isolation (Figure 1A). The center cells
in the clones showed less incorporation of DiI-LDL
(red, Figure 1B) and endothelial-specific lectin (green,
Figure 1C), which indicated that the outer cells were
differentiating endothelial cells.
Adherent cells from cryopreserved-derived UCB-MNCs
intensely bound endothelial-specific lectin (green, Figure 1D)
and took up acetylated LDL (red, Figure 1E). Double-
positive cultured MNCs (yellow, 90.02 ± 7.74%, Figure 1F,
n = 5) indicated endothelial function. PPB- and HPB-EPCs
showed 90.9 ± 11.14% and 91.04 ± 8.76% double staining
for DiI and UEA, respectively [see Additional file 1].
DiI-LDL-labeled EPCs were placed in Matrigel-based
media in which they rapidly formed capillary-like structures
(Figure 1G and H). The identity of EPCs was additionally
confirmed by the detection of multiple dense round or
rod-shaped structures (Weibel-Palade bodies) in the
electron micrographs (Figure 1I).
Figure 1 Cryopreserved umbilical cord blood mononuclear cells (UCB-MNCs) differentiated into endothelial progenitor cells (EPCs)
under endothelial cell-specific culture conditions. Culture of MNCs resulted in the emergence of colonies (A, B, and C). Cells double-labeled
for fluorescein isothiocyanate (FITC)-lectin binding (green, D) and DiI-labeled acetylated low-density lipoprotein (DiI-LDL) uptake (red, E) were
identified as EPCs (yellow, F). Tube formation assay (G and H, red arrow) indicated endothelial function. Transmission electron microscope
image of cultured cells indicates the existence of Weibel-Palade bodies, a typical superstructure of endothelial cells (I, yellow arrow).
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performed to evaluate the immunophenotype of the
cryopreserved-derived MNCs (Figure 2A) on day 0
(before differentiation) and day 7. We found increased
expression of endothelial markers (CD31, CD34, and
VEGFR2) and decreased expression of hematopoietic
stem cell markers (CD45) on day 7, indicating that the
cultured MNCs were differentiating into endothelial cells.
PPB- and HPB-MNCs (Figure 2B and C) were also
examined on day 0 and 7. Fully-differentiated HUVECs
were used as positive controls (Figure 2D).
EPC migration activity evaluation
Directed migratory responses of EPCs to SDF-1 were
performed using a modified Boyden chamber. Stimulation
with 100 ng/mL SDF-1 induced a significant increase
in migration of the PPB group (PPB versus control,P <0.05), HPB group (HPB versus control, P <0.001), and
cryopreserved UCB group (UCB versus control, P <0.001).
Furthermore, there were more migrated EPCs in the
cryopreserved UCB group and HPB group than in the
PPB group (UCB versus PPB, P <0.01; HPB versus
PPB, P <0.05) (Figure 3A). There was no difference between
the cryopreserved UCB group and the HPB group.
EPC proliferation activity evaluation
The proliferative response of EPCs to VEGF was evaluated
using MTT tetrazolium dye viability assays. Stimulation
with 100 ng/mL VEGF showed a significant increase in
proliferation of the PPB group (PPB versus control,
P <0.01), HPB group (HPB versus control, P <0.001),
and cryopreserved UCB group (UCB versus control,
P <0.001). In addition, cryopreserved UCB-EPCs and
HPB-EPCs displayed stronger proliferation than PPB-EPCs
Figure 2 Flow cytometric analysis of cultured MNCs. MNCs were cultured under endothelial cell-specific culture conditions and analyzed on
days 0 and 7. (A) Cryopreserved UCB-MNCs, (B) patient peripheral blood (PPB)-derived MNCs, (C) healthy patient peripheral blood (HPB)-derived
MNCs, and (D) human umbilical cord endothelial cells (HUVECs). MNCs, mononuclear cells; UCB, umbilical cord blood.
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(Figure 3B). There was still no difference between the
cryopreserved UCB group and the HPB group.The increase in VEGF-induced proliferation activity
was confirmed by manual counting of EPCs in the PPB
group (PPB versus control, P <0.05), HPB group (HPB
Figure 3 Evaluation of EPC biological function in vitro. (A) Migration of EPCs cultured with 100 ng/mL SDF-1, n = 9. (B) Proliferation of EPCs
cultured with 100 ng/mL VEGF, n = 9. (C) Adhesion test with 100 ng/mL SDF-1, n = 9. (D) Apoptosis test with 100 mg/L TNF-α, n = 9. PPB-control,
PPB-EPCs treated with PBS; HPB-control, HPB-EPCs treated with phosphate buffered saline (PBS); UCB-control, UCB-EPCs treated with PBS. * P <0.05;
# P <0.01, ** P <0.001; NS, not significant. EPC, endothelial progenitor cells; HPB, peripheral blood from healthy volunteers; PPB, peripheral blood from
patients; SDF-1, stromal cell derived factor 1; UBC, umbilical cord blood; VEGF, vascular endothelial growth factor.
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control, P <0.001). The number of cells in the UCB and
HPB groups was significantly greater than that of the
PPB group (UCB versus PPB, P <0.01; HPB versus PPB,
P <0.05) × 105/well [see Additional file 2]. No difference
was seen between the cryopreserved UCB group and the
HPB group.Cell adhesion assay
Incubation of EPCs with 100 ng/mL SDF-1α significantly
increased the number of adherent cells (PPB versus control,
P <0.05; HPB versus control, P <0.001; UCB versus control,
P <0.001). There was also a significant increase in the
overall number of cells in the UCB and HPB groups com-
pared to the PPB group (UCB versus PPB, P <0.01; HPB
versu. PPB, P <0.05; UCB versus HPB, P =NS) (Figure 3C).Apoptosis assay
EPCs cultured with 100 mg/L tumor necrosis factor-alpha
(TNF-α) for four days showed a significant increase in the
number of apoptosis cells in the PPB group (PPB versus
control, P <0.001), HPB group (HPB versus control,
P <0.01), and UCB group (UCB versus control, P <0.05).
There were significantly fewer apoptotic EPCs in the UCB
group and HPB groups than the PPB group (UCB versusPPB, P <0.01; HPB versus PPB, P <0.05; UCB versus HPB,
P =NS) (Figure 3D).
Cytokine release from EPCs in vitro
We measured the release of different cytokines involved
in the regulation of EPC function. As shown in Figure 4,
the release of VEGF and SDF-1 were significantly increased
in UCB-EPCs, PPB-EPCs, and HPB-EPCs compared to
MNCs and HUVECs (all P <0.001). However, there
was no difference among the UCB, PPB, and HPB groups
(all P >0.05).
Transplantation of cryopreserved EPCs promoted
reendothelialization
To determine the effect of EPC transplantation on
endothelium recovery, rats were injected with Evans
blue seven days after carotid artery injury. The blue area
was considered the denuded zone. Reendothelialization is
represented by the ratio of reendothelialized area (white)/
total area (white + blue). Endothelial cell regeneration was
significantly enhanced in the PPB-EPC, HPB-EPC, and
cryopreserved UCB-EPC treated vessels compared to the
saline injection control (PPB versus control, P <0.05; HPB
versus control, P <0.001; UCB versus control, P <0.001;
Figure 5A and B, n = 5). Furthermore, the cryopreserved
UCB-EPCs and HPB-EPCs displayed improved endothelial
Figure 4 Increased protein expression of vascular endothelial growth factor (VEGF) and stromal cell-derived growth factor 1 (SDF-1) in
EPCs compared to mature endothelial cells and MNCs. (A) A representative western blot of three independent experiments. GAPDH serves as
the loading control. (B) Protein expression quantified by densitometry analysis. The ratio for VEGF or SDF-1 loading is shown. (C and D) HUVECs,
EPCs, and MNCs were incubated with equal amounts of fresh medium for 24 hours. The medium was collected, 20× concentrated, and measured
by ELISA, n ≥ 6, ** P <0.001 versus HUVECs and MNCs. EPCs, endothelial progenitor cells; HUVECs, human umbilical venous endothelial cells;
MNCs, mononuclear cells.
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(UCB versus PPB, P <0.001; HPB versus PPB, P <0.01;
Figure 5A and B, n = 5). More endothelial cell regeneration
was also seen in the UCB group than the HPB group
(UCB versus HPB, P <0.05, Figure 5A and B). Normal
carotid artery was used as the negative control and
injured artery (day 0) was used as the positive control
[see Additional file 3]. Scanning electron microscopy
analysis revealed characteristic features of regenerated
endothelium derived from EPCs. The regenerated endothe-
lium appeared rough, whereas the surface of the normal
endothelium was smooth and covered with a monolayer
coat (Figure 5D).
Labeled EPCs are detectable in injured artery
To determine whether labeled EPCs incorporated into
the injured vessel wall and differentiated into endothelial
cells, animals received 1 × 106 DiI-labeled EPCs by tail vein
injection after carotid artery injury. Two weeks later, EPC
tracking and immunohistochemistry were performed.
DiI-labeled EPCs were identified as red fluorescence
cells (Figure 5E). Labeled cells were seen lining the
lumen that co-stained for endothelial markers FITC-UEA.
No DiI-labeled cells were identified in uninjured con-
trol arteries (data not shown). However, there were
UEA-positive cells within the neointima, indicating insitu endothelial cells (data not shown). Furthermore,
there were more homing EPCs in the cryopreserved UCB
and HPB groups than in the PPB group (Figure 5C, all
P <0.05).
Transplantation of cryopreserved EPCs inhibited
neointima
Only monolayer endothelial cells were seen along the
inner lumina of the normal carotid artery, which indicated
that there was no evidence of neointima in the sham
group. However, balloon injury resulted in prominent
neointima (Figure 6A, black arrows). Transplantation
of cryopreserved UCB-EPCs, PPB-EPCs, and HPB-EPCs
inhibited neointima development in the injured ves-
sels (PPB versus control, P <0.05; HPB versus control,
P <0.001; UCB versus control, P <0.001, Figure 6B,
n = 4, ×104 μm2). Cryopreserved UCB-EPC and HPB-EPC
infusion displayed an improved effect compared to the
PPB-EPCs (P <0.01 or P <0.05). There was no difference
in the media area among the four groups (Figure 6C).
Compared with the saline control, morphometric ana-
lysis showed a decrease in the neointima/media ratio
in EPC-transplanted rats (PPB versus control, P <0.05, HPB
versus control, P <0.001; UCB versus control, P <0.001,
Figure 6D, n = 4). UCB-EPC and HPB-EPC infusion also
displayed an improved effect compared to the PPB-EPCs
Figure 5 Homing of transplanted EPCs and reendothelialization of injured arteries. (A) Evans blue staining identified segments of denuded
(blue) and reendothelialized (white) surfaces, scale bar = 1 mm. (B) EPC transplantation promotes reendothelialization compared to the control
group, n = 5. (C) More homing UCB-EPCs and HPB-EPCs were detected than PPB-EPCs, n = 5. (D) Scanning electron microscopy analysis. The
regenerated endothelium appeared rough, whereas the surface of the normal endothelium was smooth and covered with a monolayer coat.
D1, Control; D2, PPB-EPCs; D3, HPB-EPCs; D4, UCB-EPCs; D5, Normal endothelium. (E) Homing of transfused PPB-EPCs, HPB-EPCs, and UCB-EPCs
was detected by DiI tracing and UEA co-staining in frozen sections. Scale bar = 100 μm. * P <0.05; # P <0.01, ** P <0.001; NS, not significant.
EPCs, endothelial progenitor cells; HPB-EPCs, peripheral blood derived EPCs from healthy volunteers; PPB-EPCs, peripheral blood derived EPCs
from patients; UCB, umbilical cord blood; UEA, ulex europaeus agglutinin.
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neointima area or the neointima/media ratio between
the cryopreserved UCB and HPB groups.
Discussion
In the present study, we report that the transplantation
of cryopreserved UCB-EPCs induces the recovery of
carotid artery injury in nude rats, indicating a promising
strategy for clinical therapy of patients with multiple
cardiovascular risk factors.The integrity and functional activity of the endothelial
monolayer plays a crucial role in the prevention of
atherosclerosis, a common disease in our aging world
population. It is well known that EPCs can home to
the injured zone, differentiate into endothelial cells,
and promote reendothelialization. However, impaired
quantity and quality of these vasculogenic cells in older
patients, especially with cardiovascular risk factors, such
as age, smoking, hypertension, hyperlipidemia and dia-
betes, may account for the deterioration of endothelial
Figure 6 Inhibition of neointimal proliferation by EPC transplantation in injured carotid arteries. (A) H & E staining of injured arteries or
sham group. Scale bar = 100 μm. (B) Quantified intima area. (C) Quantified media area. (D) Neointima/media ratios. * P <0.05, # P <0.01, ** P <0.001;
NS, not significant, n = 4. EPC, endothelial progenitor cells.
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EPCs from patients with diabetes, hypertension, coronary
artery disease, or aging are associated with impaired
migration, proliferation, adhesion, and survival capabilities.
Although there is no difference in VEGF and SDF-1 release,
our in vivo study showed that infusion of dysfunctional
peripheral EPCs led to decreased recovery of carotid
artery injury than healthy EPCs.
Previous studies have shown that the transplantation of
UCB-EPCs represents a promising therapeutic strategy
for multiple cardiovascular diseases [19]. In 2007, it
was reported that EPCs could be isolated from frozen
UCB mononuclear cells stored at −196°C for 0.2 to
5 years and differentiated into endothelial cells [9],
suggesting that ex vivo culture is a useful method for
collection of EPCs from cryopreserved UCB–derived
MNCs. Other studies also found that the ‘late’ EPCs
from cryopreserved MNCs were phenotypically and
functionally indistinguishable from freshly isolated
ones, including the ability to form blood vessels
in vivo [10,11]. Thus, private collecting of cryopre-
served UCB units may provide large quantity andhigh quality EPCs for personal autotransplantation or
matched-patient allotransplantation.
We successfully obtained cluster-forming EPCs from
cryopreserved UCB-MNCs, which, based on the time and
appearance, seem like late EPCs [20,21]. These progenitors
have the capability of tube formation, UEA-binding,
Ac-LDL (acetylated low-density lipoprotein) uptake, and ex-
pression of endothelial membrane antigens. Furthermore,
we also identified Weibel-Palade bodies, the specific ultra-
structure of endothelial cells, using electron micrographs.
EPC-mediated paracrine signaling has been shown to
be critical in reendothelialization and neovascularization
by activating adjacent endothelial cells and enhancing
angiogenesis [22,23]. Thus, we checked the secretion of
cytokines in the culture medium and found a significant
increase in the expression of VEGF and SDF-1 during
EPC differentiation.
EPCs can be obtained from MNCs and from puri-
fied populations of CD34-positive, CD133-positive, or
CD14-positive hematopoietic cells [2,20,21,24]. However,
Lu et al. found that they were unable to generate
endothelial-like cells from cryopreserved cord blood (CB)
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may be due to the different isolation method they used.
Moreover, Jun-ho et al. compared the potential of cryo-
preserved UCB-EPCs with those from healthy volunteers’
fresh PB (HPB). They found no difference in VEGF secre-
tion and proliferation between the two groups [9]. We
found that UCB-EPCs and HPB-EPCs showed a
higher capacity for migration, proliferation, survival, and
adherence than PPB-EPCs, indicating the well preserved
potential of cryopreserved UCB-EPCs. Nevertheless,
similar membrane antigen and cytokines, such as VEGF
and SDF-1, were expressed with PPB-EPCs.
Absence or delay of reendothelialization is the initial
step for thrombosis and neointimal hyperplasia, which leads
to in-stent restenosis and subsequently tissue ischemia.
However, few studies have been performed to evaluate the
availability of cryopreserved autologous UCB-EPCs for
transplantation. In this study, DiI-labeled EPCs were
located in the injured site, and bound to the UEA
specific endothelial marker, indicating differentiated
endothelial cells. We also found that the transplantation
of cryopreserved UCB-EPCs, PPB-EPCs, and HPB-EPCs
increased reendothelialization of the denuded vessels and
reduced neointima formation. Furthermore, compared
with the PPB group, more homing EPCs were observed in
the cryopreserved UCB and HPB groups, which may have
subsequently resulted in accelerated reendothelialization
and reduced neointimal formation.
Conclusions
These results show that cryopreserved UCB-EPCs and
HPB-EPCs are functionally stronger in vitro and have
a greater effect on vascular repair than ‘unhealthy
PB-EPCs’ after in vivo transplantation. Thus, cryo-
preservation and delivery of cryopreserved autogenous
UCB-EPCs or HPB-EPCs may be a promising vasculopro-
tective approach for patients with multiple cardiovascular
risk factors.Additional files
Additional file 1: DiI and UEA double staining of cultured PPB-EPCs
and HPB-EPCs. Adherent cells from PPB-MNCs (upper) and HPB-MNCs
(lower) bound endothelial-specific lectin (green, A1, A2) and took up
acetylated LDL (red, B1, B2). Double-positive cultured MNCs (yellow,
90.9 ± 11.14% for PPB-MNCs, 91.04 ± 8.76% for HPB-MNCs; C1, C2, n = 5).
Additional file 2: Manual counting of EPCs in the PPB, HPB, and
UCB groups. VEGF-induced proliferative activity was confirmed by
manual counting of EPCs. The number of cells in the UCB and HPB
groups was significantly greater than that in the PPB group. NS, not
significant; * P <0.05; # P <0.01, (×105/well, n = 5).
Additional file 3: Control of Evans blue staining and EPC tracking.
(A) Normal carotid artery serves as the negative control. (B) Injured artery
(day 0) serves as the positive control. (C) No DiI-labeled cells (red) were
identified in uninjured control arteries. (D) There were UEA-positive cells
within the intima in uninjured control arteries.Abbreviations
DiI-LDL: DiI-labeled acetylated low-density lipoprotein; DMEM: Dulbecco’s
modified Eagle’s medium; DMSO: dimethyl sulfoxide; ELISA: enzyme-linked
immunosorbent assay; EPCs: endothelial progenitor cells; FBS: fetal bovine
serum; FITC: fluorescein isothiocyanate; HPB-EPCs: peripheral blood derived
EPCs from healthy volunteers; HSCs: hematopoietic stem cells;
HUVECs: human umbilical venous endothelial cells; MNCs: mononuclear cells;
PB: peripheral blood; PBS: phosphate-buffered saline; PFA: paraformaldehyde;
PPB-EPCs: peripheral blood derived EPCs from patients; SDF-1: stromal cell
derived factor 1; TNF: tumor necrosis factor; UCB: umbilical cord blood;
UEA: FITC-labeled lectin from ulex europaeus agglutinin; VEGF: vascular
endothelial growth factor.
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